Atopic dermatitis: Tacrolimus vs. topical corticosteroid use
Atopic dermatitis (AD), the dermatological manifestation of the atopic diathesis, has a variety of clinical presentations. It is a chronic and relapsing inflammatory disorder, requiring a multifaceted treatment approach. Topical corticosteroids are the backbone of therapy. However, concerns over adv...
Saved in:
| Main Authors: | Y. Langa, E. van der Merwe |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
AOSIS
2011-07-01
|
| Series: | South African Family Practice |
| Subjects: | |
| Online Access: | https://safpj.co.za/index.php/safpj/article/view/1762 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
ATOPIC DERMATITIS: NEW TARGETS OF THERAPY
by: D. Sh. Macharadze
Published: (2014-07-01) -
Corticosteroid-induced skin damage improved with pimecrolimus cream 1% treatment: a 1-year study in adults with mild to moderate atopic dermatitis
by: Diamant Thaçi, et al.
Published: (2025-12-01) -
Efficacy of dupilumab plus topical corticosteroids in children with atopic dermatitis: A meta‐analysis of randomized controlled trials
by: Li Wang, et al.
Published: (2024-01-01) -
Canadian Consensus Guidelines for the Management of Atopic Dermatitis with Topical Therapies
by: Melinda J. Gooderham, et al.
Published: (2025-04-01) -
Predictors of Topical Corticosteroid Adherence Among Caregivers of Children with Atopic Eczema
by: Liew ELF, et al.
Published: (2025-05-01)